Great progress in imaging and therapy with radioimmunoconjugates was discussed at the fourth conference on radioimmunodetection and radioimmunotherapy of cancer. Monoclonal antibody-based cancer imaging agents are awaiting marketing approval and newer, potentially improved forms are in development. Tumor responses to radioimmunoconjugates are also being reported in increasing numbers, this is especially so with radiosensitive tumors and in regional or direct applications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0167-5699(93)90315-C | DOI Listing |
Publication Analysis
Top Keywords
coming age
4
age cancer
4
cancer radioimmunoconjugates
4
radioimmunoconjugates great
4
great progress
4
progress imaging
4
imaging therapy
4
therapy radioimmunoconjugates
4
radioimmunoconjugates discussed
4
discussed fourth
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!